Inactive

PERFORMANCE WORK STATEMENT The Centralized Laboratory Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) owns sequencing instruments such as Miseq and Miniseq, both of which are us... PERFORMANCE WORK STATEMENT The Centralized Laboratory Department of the U.S. Naval Medical Research Unit SOUTH (NAMRU SOUTH) owns sequencing instruments such as Miseq and Miniseq, both of which are used in Next-Generation Sequencing (NGS) laboratory procedures. Most NGS projects are based on pathogen discovery in human and non-human samples using the above sequencers. These platforms employ sequencing by synthesis technology, integrating cluster generation, amplification, sequencing, and data analysis into a single instrument. We use targeted, random and shotgun sequencing of public health pathogens such as respiratory viruses and arboviruses. Due to time elapsed since their acquisition, high daily performance, and extremely costly price of brand-new instruments, our department needs to contract the extended warranty of one year for the Illumina instruments (MiSeq, S/N M02743, MiniSeq, S/N MN00730), which should include full coverage for parts replacement, reagents replacement upon hardware failure, onsite support, and both preventive and corrective maintenance when required. Current warranty of instruments expires on the following dates: Miseq S/N M02743: 16 September 2025 Miniseq S/N MN00730: 28 September 2025 NAMRU SOUTH requires the above detailed services for both instruments considering it is essential to keep working at optimum and full capacity. Contract needs to start no later than September 1, 2025, for vendor to have ample time to provide us with warranty letters.